Lupin launches chronic angina treatment drug in the US
The newly-launched product, in strengths of 500 mg and 1,000 mg, is a generic version of Gilead Sciences' Ranexa ER tablets
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Govt brings 42 non-scheduled cancer drugs under price control
Currently, 57 anti-cancer drugs are under price control as scheduled formulations
Merck launches cutting-edge fertility technologies in India
The two devices Gavi and Geri will help to reduce external stresses on the embryos of patients undergoing fertility treatment
Pharma exports likely to touch $19 billion in 2018-19: Prabhu
Some important factors have affected exports recently, especially to the US, Suresh Prabhu said
PPL Conclave 2019 | Session Highlights Video Compilation | Day 1 & 2
PPL Conclave 2019 | Session Highlights Video Compilation | Day 1 & 2
16th BioAsia 2019 kicks off with industry stalwarts from India and abroad
Governor of Telangana launches state government’s vaccine skilling programme for students to encourage professionals in the…
Glenmark Pharmaceuticals announces results from new analysis of pooled data on Ryaltris
Ryaltris, formerly GSP 301 Nasal Spray, is the respiratory pipeline asset and currently under review with the US Food and Drug…
Lupin receives FDA approval for Methylprednisolone Tablets
These tablets are used to treat endocrine disorders, rheumatic disorders, collagen diseases, dermatologic diseases, allergic…
Ipsen to buy Clementia Pharmaceuticals in deal worth up to $1.3 billion
The companies said the initial cash offer of $25 per share marked a premium of around 70 per cent to Clementia’s recent average…
AIIMS and University College London ink pact for research collaborations
A formal "Letter of Intent" was signed between UCL's President Professor Michael Arthur and AIIMS Director Professor Randeep…